Literature DB >> 31726475

From primordial gas to the medicine cabinet.

Andreas Papapetropoulos1, John L Wallace2, Rui Wang3.   

Abstract

LINKED ARTICLES: This article is part of a themed section on Hydrogen Sulfide in Biology & Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.4/issuetoc.
© 2020 The British Pharmacological Society.

Mesh：

Substances：

Year:  2020        PMID： 31726475      PMCID： PMC7024704          DOI： 10.1111/bph.14929

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  36 in total

Review 1.  Physiological implications of hydrogen sulfide: a whiff exploration that blossomed.

Authors:  Rui Wang
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

2.  A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug.

Authors:  John L Wallace; Peter Nagy; Troy D Feener; Thibault Allain; Tamás Ditrói; David J Vaughan; Marcelo N Muscara; Gilberto de Nucci; Andre G Buret
Journal:  Br J Pharmacol       Date:  2019-04-11       Impact factor: 8.739

3.  Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?

Authors:  Rui Wang
Journal:  FASEB J       Date:  2002-11       Impact factor: 5.191

4.  AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.

Authors:  Bartosz Szczesny; Katalin Módis; Kazunori Yanagi; Ciro Coletta; Sophie Le Trionnaire; Alexis Perry; Mark E Wood; Matthew Whiteman; Csaba Szabo
Journal:  Nitric Oxide       Date:  2014-04-19       Impact factor: 4.427

5.  Hydrogen sulfide regulates muscle RING finger-1 protein S-sulfhydration at Cys44 to prevent cardiac structural damage in diabetic cardiomyopathy.

Authors:  Xiaojiao Sun; Dechao Zhao; Fangping Lu; Shuo Peng; Miao Yu; Ning Liu; Yu Sun; Haining Du; Bingzhu Wang; Jian Chen; Shiyun Dong; Fanghao Lu; Weihua Zhang
Journal:  Br J Pharmacol       Date:  2019-04-29       Impact factor: 8.739

Review 6.  Calciphylaxis: risk factors, diagnosis, and treatment.

Authors:  Sagar U Nigwekar; Daniela Kroshinsky; Rosalynn M Nazarian; Jeremy Goverman; Rajeev Malhotra; Vicki Ann Jackson; Mihir M Kamdar; David J R Steele; Ravi I Thadhani
Journal:  Am J Kidney Dis       Date:  2015-05-07       Impact factor: 8.860

Review 7.  Signalling by hydrogen sulfide and polysulfides via protein S-sulfuration.

Authors:  Hideo Kimura
Journal:  Br J Pharmacol       Date:  2019-03-04       Impact factor: 8.739

8.  H2S signals through protein S-sulfhydration.

Authors:  Asif K Mustafa; Moataz M Gadalla; Nilkantha Sen; Seyun Kim; Weitong Mu; Sadia K Gazi; Roxanne K Barrow; Guangdong Yang; Rui Wang; Solomon H Snyder
Journal:  Sci Signal       Date:  2009-11-10       Impact factor: 8.192

Review 9.  The role of H2S bioavailability in endothelial dysfunction.

Authors:  Rui Wang; Csaba Szabo; Fumito Ichinose; Asif Ahmed; Matthew Whiteman; Andreas Papapetropoulos
Journal:  Trends Pharmacol Sci       Date:  2015-06-09       Impact factor: 14.819

10.  Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease.

Authors:  Katalin Éva Sikura; László Potor; Tamás Szerafin; Melinda Oros; Péter Nagy; Gábor Méhes; Zoltán Hendrik; Abolfazl Zarjou; Anupam Agarwal; Niké Posta; Roberta Torregrossa; Matthew Whiteman; Ibolya Fürtös; György Balla; József Balla
Journal:  Br J Pharmacol       Date:  2019-04-24       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.